Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

In vitro studies point to potent, long-lasting antiplatelet effects for XV-459/DMP-754

Oct. 26, 1998

Platelet collagen receptors targeted for development of new antiplatelet therapies

Oct. 23, 1998

Effects of DX-9065a on platelet activation reported at international congress

Oct. 23, 1998

SR-121787: the most potent fibrinogen antagonist reported to date

Oct. 23, 1998

New antiplatelet agents in the pipeline at Astra

Oct. 22, 1998

DuPont discloses heteroaromatic factor Xa inhibitors

Oct. 22, 1998

FDA Cardiovascular and Renal Drugs Advisory Committee meets this week

Oct. 20, 1998

Phase I study results reported for rNAPc2; further testing of novel anticoagulant recommended

Oct. 20, 1998

5-HT2A receptor antagonist shows potent antithrombotic activity in rat model

Oct. 19, 1998

Orally active thrombin inhibitors prepared at ADIR as anticoagulants

Oct. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...